Research at Rabin Medical Center

Establishing the fibrinogen-like protein 2 (FGL2) as a novel biomarker and a therapeutic target for cancer diagnosis

By: Dr. Esther Rabizadeh and Dr. Izhack Cherny

Location: Hematology Laboratory, Rabin Medical Center

This particular research project focuses on cancer diagnosis or detection. The goal is to enable the identification of cancer development in human individuals through a simple blood test. The proposed test should be adequately reliable, inexpensive and not limited to a specific type of cancer disease. The idea is to use the FGL2 prothrombinase test in the course of routine checkups, allowing the alert of a possible malignancy. To manifest this vision, we are still requiring screening larger cohorts of patients with wide range of malignant diseases as well as normal controls.

If the FGl2 is targeted then this may be an effective approach for cancer therapy and perhaps the inhibition of FGL2 in cancer cells.

Funding Request: $25,000

If you would like to donate and learn more click here.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s